-
平臺(tái)編號(hào)：bio-117766
-
國(guó)際編號(hào)：DSM 1986
-
拉丁屬名： Phenylobacterium immobile
-
規(guī)格：凍干粉/培養(yǎng)物
-
用途：DSM原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu) 說(shuō)明書(shū)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類(lèi)或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
中文名稱(chēng)暫無(wú)
Name:
Phenylobacterium immobile Lingens et al. 1985
DSM No.:
1986, Type strain
Strain designation:
E
Other collection no.
or WDCM no.:
ATCC 35973,NCIB 12055
Isolated from:
soil, enrichment with chloridazon
Country:
Ecuador
Date of sampling:
before 09.12.1980
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- F. Lingens; E <- C. Fr?hner
Cultivation conditions:
Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days), 28°C
or
Medium 464 (diluted 1:3), 28°C
or
Medium 830 , 28°C
or
Medium 462 , +0,4g/L Antipyrin, 28°C
Complete DSMZ Media List
Summary and
additional information:
<- F. Lingens; E <- C. Fr?hner. Soil, enrichment with chloridazon; Ecuador (2945). Type strain. Taxonomy/description (2944, 2955). Plasmids (2957). Produces catechol-2,3-dioxygenase (2949), pyrazon dioxygenase (2948), dihydrodiols from phenylalanine (2951), 2-keto-4-hydroxy valeric acid (2950). Utilizes antipyrin (analgetic) (2947), chloridazon (2944), trans-cinnamic acid (2956). Composition of lipopolysaccharide (2952). Rhodanese activity (2953). Serological studies (2954). (Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days) or medium 464 (diluted 1:3), 28°C).
Literature:
2944, 2945, 2946, 2947, 2948, 2949, 2950, 2951, 2952, 2953, 2954, 2955, 2956, 2957
Risk group:
1 (classification according to German TRBA)
Supplied as:
Delivery form Prices
Price Category for this culture: 1
Freight and handling charges will be added. See price list.
Phenylobacterium immobile Lingens et al. 1985
DSM No.:
1986, Type strain
Strain designation:
E
Other collection no.
or WDCM no.:
ATCC 35973,NCIB 12055
Isolated from:
soil, enrichment with chloridazon
Country:
Ecuador
Date of sampling:
before 09.12.1980
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- F. Lingens; E <- C. Fr?hner
Cultivation conditions:
Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days), 28°C
or
Medium 464 (diluted 1:3), 28°C
or
Medium 830 , 28°C
or
Medium 462 , +0,4g/L Antipyrin, 28°C
Complete DSMZ Media List
Summary and
additional information:
<- F. Lingens; E <- C. Fr?hner. Soil, enrichment with chloridazon; Ecuador (2945). Type strain. Taxonomy/description (2944, 2955). Plasmids (2957). Produces catechol-2,3-dioxygenase (2949), pyrazon dioxygenase (2948), dihydrodiols from phenylalanine (2951), 2-keto-4-hydroxy valeric acid (2950). Utilizes antipyrin (analgetic) (2947), chloridazon (2944), trans-cinnamic acid (2956). Composition of lipopolysaccharide (2952). Rhodanese activity (2953). Serological studies (2954). (Medium 363 (for reactivation, incubate lyophilised cells in liquid medium for up to 14 days) or medium 464 (diluted 1:3), 28°C).
Literature:
2944, 2945, 2946, 2947, 2948, 2949, 2950, 2951, 2952, 2953, 2954, 2955, 2956, 2957
Risk group:
1 (classification according to German TRBA)
Supplied as:
Delivery form Prices
Price Category for this culture: 1
Freight and handling charges will be added. See price list.
